| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |